Advisors Asset Management, Inc. - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 262 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.

Quarter-by-quarter ownership
Advisors Asset Management, Inc. ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$166,574
+245.9%
7,993
+297.5%
0.00%
+300.0%
Q2 2023$48,163
+59.9%
2,011
+6.3%
0.00%0.0%
Q4 2022$30,121
-92.3%
1,892
-92.1%
0.00%
-87.5%
Q3 2022$392,000
+13.6%
23,938
-2.3%
0.01%
+14.3%
Q2 2022$345,000
-49.5%
24,491
-13.1%
0.01%
-36.4%
Q1 2022$683,000
-2.7%
28,197
-6.2%
0.01%
+10.0%
Q4 2021$702,000
+38.5%
30,059
-1.6%
0.01%
+25.0%
Q3 2021$507,000
-32.4%
30,535
-0.8%
0.01%
-27.3%
Q2 2021$750,000
+2.3%
30,767
+8.3%
0.01%0.0%
Q1 2021$733,000
-8.5%
28,402
+89.5%
0.01%
-15.4%
Q4 2020$801,000
+430.5%
14,988
+309.8%
0.01%
+333.3%
Q3 2020$151,000
+58.9%
3,657
+86.3%
0.00%
+50.0%
Q2 2020$95,000
-37.1%
1,963
-80.2%
0.00%
-33.3%
Q2 2018$151,000
-47.4%
9,897
-14.1%
0.00%
-40.0%
Q1 2018$287,000
-20.9%
11,518
-4.5%
0.01%
-16.7%
Q4 2017$363,000
-27.3%
12,060
-9.0%
0.01%
-25.0%
Q3 2017$499,000
+22.6%
13,258
-9.2%
0.01%
+14.3%
Q2 2017$407,000
-22.0%
14,609
-3.8%
0.01%
-22.2%
Q1 2017$522,000
+13.0%
15,188
-5.1%
0.01%
+12.5%
Q4 2016$462,000
+58.8%
16,012
+75.1%
0.01%
+60.0%
Q3 2016$291,0009,1460.01%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Finepoint Capital LP 556,553$11,598,5655.78%
Baker Brothers Advisors 42,864,612$893,298,5145.15%
RTW INVESTMENTS, LP 11,576,537$241,255,0315.09%
Palo Alto Investors LP 2,405,793$50,136,7264.74%
Birchview Capital, LP 240,400$5,009,9364.26%
EcoR1 Capital, LLC 5,991,479$124,862,4224.21%
EMERALD ADVISERS, LLC 1,681,052$35,033,1241.70%
EMERALD MUTUAL FUND ADVISERS TRUST 1,303,988$27,175,1101.64%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 179,702$3,739,5991.26%
SECTOR GAMMA AS 179,785$3,746,7190.96%
View complete list of ACADIA PHARMACEUTICALS INC shareholders